FKBP51 protects 661w cell culture from staurosporine-induced apoptosis

Molecular Vision

Volumn 17, Issue , 2011, Pages 1172-1181

  Daudt, Donald Raymond ^a   Yorio, Thomas ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 51; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STAUROSPORINE; TACROLIMUS; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; MOUSE; NERVE CELL; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; GENE EXPRESSION; MICE; NERVE DEGENERATION; NEURONS; NEUROPROTECTIVE AGENTS; NF-KAPPA B; PLASMIDS; RETINA; STAUROSPORINE; TACROLIMUS; TACROLIMUS BINDING PROTEINS; TRANSFECTION;

EID: 79957461151     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Calabrese V, Corneliius C, Mancuso C, Pennisi G, Calafato S, Bellia F, Bates TE, Giuffrida Stella AM, Schapira T, Dinkova Kostova AT, Rizzarelli E. Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. Neurochem Res 2008; 33:2444-71. [PMID: 18629638]
2. Miksys SL, Tyndale RF. Neurodegenerative diseases: a growing challenge. Clin Pharmacol Ther 2010; 88:427-30. [PMID: 20856233]
3. Okouchi M, Ekshyyan O, Maracine M, Aw TY. Neuronal Apoptosis in Neurodegeneration. Antioxid Redox Signal 2007; 8:1059-96.
4. Waldmeier PC, Tatton WG. Interrupting apoptosis in neurodegenerative disease: potential for effective therapy? Drug Discov Today 2004; 9:210-8. [PMID: 14980539]
5. Freeman EE, Grosskreutz CL. The effects of FK506 on retinal ganglion cells after optic nerve crush. Invest Ophthalmol Vis Sci 2000; 41:1111-5. [PMID: 10752948]
6. Giordani F, Benetolli A, Favero-Filho LA, Lima KC, Cestari Junior L, Milani H. Tacrolimus (FK506) reduces ischemiainduced hippocampal damage in rats: a 7- and 30-day study. Braz J Med Biol Res 2003; 36:495-502. [PMID: 12700828]
7. Kaminska B, Gaweda-Walerych K, Zawadzka M. Molecular mechanisms of neuroprotective action of immunosuppressants-facts and hypotheses. J Cell Mol Med 2004; 8:45-58. [PMID: 15090260]
8. Huang W, Fileta JB, Dobberfuhl A, Filippopolous T, Guo Y, Kwon G, Grosskreutz CL. Calcineurin cleavage is triggered by elevated intraocular pressure, and calcineurin inhibition blocks retinal ganglion cell in experimental glaucoma. Proc Natl Acad Sci USA 2005; 102:12242-7. [PMID: 16103353]
9. Szydlowska K, Gozdz A, Dadrowski M, Zawadzka M, Kaminska B. Prolonged activation of ERK triggers glutamate-induced apoptosis of astrocytes: Neuroprotective effect of FK506. J Neurochem 2010; 113:904-18. [PMID: 20202085]
10. Ormerod AD. Topical tacrolimus and pimecrolimus and the risk of cancer: how much cause for concern? Br J Dermatol 2005; 153:701-5. [PMID: 16181449]
11. Weischer M, Rocken M, Berneburg M. Calcineurin inhibitors and rapamycin: cancer protection or promotion. Exp Dermatol 2007; 16:385-93. [PMID: 17437481]
12. Tanaka K, Fujita N, Higashi Y, Ogawa N. Neuroprotective and antioxidant properties of FKBP-binding immunophilin ligands are independent on the FKBP12 pathway in human cells. Neurosci Lett 2002; 330:147-50. [PMID: 12231433]
13. Guo X, Dawson VL, Dawson TM. Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons. Eur J Neurosci 2001; 13:1683-93. [PMID: 11359520]
14. Burnett A, Kramer M, Dalrymple S, Isaacs J. Nonimmunosuppressant immunophilin ligand GPI-1046 does not promote in vitro growth of prostate cancer cells. Urology 2003; 65:1003-7.
15. Klettner A, Herdegen T. FK506 and its analogs - therapeutic potential for neurological disorders. Curr Drug Target CNS Neurol Disord 2003; 2:153-62.
16. Giraudier S, Chagraoui H, Komura E, Barnache S, Blanchet B, LeCouedic JP, Smith DF, Larbret F, Taksin AL, Moreau- Gachelin F, Casadevall N, Tulliez M, Hulin A, Debili N, Vainchenker W. Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors. Blood 2002; 100:2932-40. [PMID: 12351405]
17. Komura E, Chagraoui H, Mansat De Mas V, Blanchet B, de Sepulveda P, Larbret F, Larghero J, Tulliez M, Debili N, Vainchenker W, Giraudier S. Spontaneous STAT5 activation induces growth factor independence in idiopathic myelofibrosis: possible relationshiop with FKBP51 overexpression. Exp Hematol 2003; 31:622-30. [PMID: 12842707]
18. Krappmann D, Scheidereit C. A pervasive role of ubiquitin conjugation in activation and termination of IkappaB kinase pathways. EMBO Rep 2005; 6:321-6. [PMID: 15809659]
19. Fahy BN, Schlieman M, Virudachalam S, Bold RJ. AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2. Br J Cancer 2003; 89:391-7. [PMID: 12865934]
20. Romano S, D'Angelillo A, Pacelli R, Staibano S, De Luna E, Bisogni R, Eskelinen EL, Mascolo M, Cali G, Arra C, Romano MF. Role of FK506-binding protein 51 in the control of apoptosis of irradiated melanoma cells. Cell Death Differ 2002; 17:145-57.
21. Dolga AM, Granic I, Blank T, Knaus HG, Spiess J, Luiten PG, Eisel UL, Nijholt IM. TNF-alpha-mediates neuroprotection against glutamate-induced excitotoxicity via NF-kappaBdependent up-regulation of K2.2 channels. J Neurochem 2008; 107:1158-67. [PMID: 18823372]
22. Burnette WN. Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 1981; 112:195-203. [PMID: 6266278]
23. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-5. [PMID: 5432063]
24. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76:4350-4. [PMID: 388439]
25. Krohn AJ, Preis E, Prehn JH. Staurosporine-induced apoptosis of cultured rat hippocampal neurons involves caspase-1-like proteases as upstream initiators and increased production of superoxide as a main downstream effector. J Neurosci 1998; 18:8186-97. [PMID: 9763465]
26. Cereghetti GM, Costa V, Scorrano L. Inhibition of Drp1- dependent mitochondrial fragmentation and apoptosis by a polypeptide antagonist of calcineurin. Cell Death Differ 2010; 17:1785-94. [PMID: 20489733]
27. Shi C, Wu F, Yew DT, Xu J, Zhu Y. Bilobalide prevents apoptosis through activation of the PI3K/Akt pathway in SHSY5Y cells. Apoptosis 2010; 15:715-27. [PMID: 20333467]
28. Tan E, Ding XQ, Saadi A, Agarwal N, Naash MI, Al-Ubaidi MR. Expression of con-photoreceptor-specific antigens in a cell line derived from retinal tumors in transgenic mice. Invest Ophthalmol Vis Sci 2004; 43:764-8.
29. Krishnamoorthy RR, Rao VR, Dauphin R, Prasanna G, Johnson C, Yorio T. Role of the ETB receptor in retinal ganglion cell death in glaucoma. Can J Physiol Pharmacol 2008; 86:380-93. [PMID: 18516102]
30. Pizzi M, Spano P. Distinct roles of diverse nuclear factor kB complexes in neuropathological mechanism. Eur J Pharmacol 2006; 545:22-8. [PMID: 16854410]
31. Mattson MP, Culmsee C, Yu ZF, Camldola S. Roles of nuclear factor-kB in neuronal survival and plasticity. J Neurochem 2000; 74:443-56. [PMID: 10646495]
32. Beg AA, Baltimore D. An essential role for NF-kB in preventing TNF-alpha-induced cell death. Science 1996; 274:782-4. [PMID: 8864118]
33. Barger SW, Horster D, Furukawa K, Goodman Y, Krieglestein J, Mattson MP. Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of kB-binding factor and attenuation of peroide and Ca++ accumulation. Proc Natl Acad Sci USA 1995; 92:9328-32. [PMID: 7568127]
34. Lyons WE, George EB, Dawson TM, Steiner JP, Snyder SH. Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia. Neurobiology 1994; 91:3191-5.
35. Febbo PG, Lowenberg M, Thorner AR, Brown M, Loda M, Golub TR. Androgen mediated regulation and functional implications of fkbp51 expression in prostate cancer. J Urol 2005; 173:1772-7. [PMID: 15821585]
36. Makkonen H, Kauhanen M, Paakinaho V, Jaaskelainen T, Palvimo JJ. Long-range activation of FKBP51 transcription by the androgen receptor via distal intronic enhancers. Nucleic Acids Res 2009; 11:1-14.
37. Ni L, Yang CS, Gioeli D, Frierson H, Toft DO, Paschal BM. FKBP51 promotes assembly of the HSp90 chaperone complex and regulates androgen receptor signaling in prostate cancer cells. Mol Cell Biol 2010; 30:1243-53. [PMID: 20048054]
38. Bock O, Neusch M, Büsche G, Mengel M, Kreipe H. Constitutive expression of the FK506 binding protein 51 (FKBP51) in bone marrow cells and megakaryocytes derived from idiopathic myelofibrosis and non-neoplastic haematopoiesis. Eur J Haematol 2004; 72:239-44. [PMID: 15089760]
39. Jinwal UK, Koren J III, Borysov SI, Schmid AB, Abisambra JF, Blair LJ, Johnson AG, Jones JR, Shults CL, O'Leary JC III, Jin Y, Buchner J, Cox MB, Dickey CA. The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules. J Neurosci 2010; 30:591-9. [PMID: 20071522]
40. Komura E, Tonetti C, Penard-Lacronique V, Chagraoui H, Lacout C, Lecouédic JP, Rameau P, Debili N, Vainchenker W, Giraudier S. Role for the nuclear factor kappaB pathway in transforming growth factor-beta1 production in idiopathic myelofibrosis: possible relationship with FK506 binding protein 51 overexpression. Cancer Res 2005; 65:3281-9. [PMID: 15833861]
41. Harper S, Bilsland J, Young L, Bristow L, Boyce S, Mason G, Rigby M, Hewson L, Smith D, O'Donnell R, O'Conner D, Hill RG, Evans D, Swain C, Williams B, Hefti F. Analysis of neurotrophic effects of GPI-1046 on neuron survival and regeneration in culture and in vivo. Neuroscience 1999; 88:257-67. [PMID: 10051205]
42. Moss SJ, Birkestrand B, Fowler SC. The neuroimmunophilin GPI-1046 partially protects against 3-acetylpyridine toxicity in the rat. Neurosci Lett 2002; 321:53-6. [PMID: 11872255]
43. Kuntzen C, Zazzeroni F, Pham CG, Papa S, Bubici C, Knabb JR, Franzoso G. A method for isolating prosurvival targets of NF-kB/Rel transcption factors. Methods Mol Biol 2007; 399:99-124. [PMID: 18309928]
44. Wooten MW. Function of NF-kB in neuronal survival: regulation by atypical protein kinase C. J Neurosci Res 1999; 58:607-11. [PMID: 10561688]
45. Du S, Hiramatsu N, Hayakawa K, Kasai A, Okamura M, Huang T, Yao J, Takeda M, Araki I, Sawada N, Paton AW, Paton JC, Kitamura M. Suppression of NF-kB by cyclosporine A and Tacrolimus (FK506) via induction of the C/EBP Family: Implication of Unfolded protein response. J Immunol 2009; 182:7201-11. [PMID: 19454717]
46. Muraoka K, Fujimoto K, Sun X, Yoshioka K, Shimizu K, Yagi M, Bose H Jr, Miyazaki I, Yamamoto K. Immunosuppresant FK506 induces interleukin-6 production through the activation of transcription factor nuclear factor (NF)-κ. B. J. Clin. Invest. 1996; 97:2433-9.